Dunad Therapeutics is a transatlantic biotech company with operations in Cambridge, United Kingdom, and Boston in the United States. The company focuses on innovative therapeutics research and development with a small team of specialized scientists.
Subscribe to see Dunad Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Dunad Therapeutics is a biotechnology company headquartered in United Kingdom, founded in 2020. Xcout tracks 8 named people at Dunad Therapeutics, including Pearl Huang (President & CEO).
2 more named people on record for Dunad Therapeutics, with roles, board committees and tenure — see the full roster →
A few of Dunad Therapeutics's closest competitors — see the full list of competitors and alternatives →
Vivatides Therapeutics Inc. is a privately held biotechnology company founded in 2025 and headquartered in Woburn, Massachusetts. The company maintains a small team focused on therapeutics research and development.
Delphia Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts, with a team of 11 to 50 employees focused on therapeutic innovations.
Apollo Therapeutics is a biopharmaceutical company with headquarters located in Cambridge, United Kingdom, alongside offices in Boston, Massachusetts. The company advances breakthrough science to build a portfolio of innovative therapeutics.
DynamiCure Biotechnology is a life sciences company applying innovative approaches to drug discovery from its facilities in Waltham, Massachusetts.
Bambusa Therapeutics is a biotechnology research company with roots in Victoria, Australia, and an office in Boston, Massachusetts. It focuses on biotech research and development.
Valink Therapeutics Inc. is a biotechnology research company headquartered in Cambridge, Massachusetts, with a research and development subsidiary located in London, United Kingdom.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.